Gene Therapy Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gene therapy committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gene Therapy Committee Today - Breaking & Trending Today

BioCentriq Hires David Smith as Vice President of Development

/PRNewswire/ BioCentriq, Inc. a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO) announced today that. ....

David Smith , Haro Hartounian , Biotechnology Committee , Development Subcommittee , Loughborough University , Biotechnology Advisory Panel , Commercialization Committee , Gene Therapy Committee , Analytical Method Development , Prnewswire Biocentriq Inc , New Jersey Based , Vice President , Process Development , Analytical Method , Technical Operations , Ori Biotech , Minaris Regenerative , Regenerative Medicine , Therapy Advisory , Process Development Subcommittee , Advisory Panel , Health Care Amp Hospitals , Personnel Announcements ,

Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego

/PRNewswire/ Dr. Serhat Gumrukçu, inventor and co-founder of Enochian BioSciences and Director of Research at the Seraph Research Institute, was invited to. ....

United States , Enochian Bioscience , Los Angeles , Serhat Gumruk , Mark Dybul , Anahid Jewett , Enochian Biosciences , Medicine Association , Vaccines Committee , American Society Of Clinical Oncology , American Society Of Gene Cell Therapy , Jp Morgan Founders Forum , Scientific Program Committee For The Summit , Seraph Research Institute , Translational Research , Cancer Cell Gene Therapy Committee , Scientific Program Committee , American Journal Case Reports , Looking Statements , Annual Report , Executive Director , American Society , Clinical Oncology , European Association , Cell Therapy , Cancer Cell ,

Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors

Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors
News provided by
Share this article
Share this article
AUSTIN, Texas, Dec. 17, 2020 /PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high burden diseases, today announced the appointment of Alison Lawton to its Board of Directors. Ms. Lawton previously served as president and CEO of Kaleido Biosciences.
We are pleased to welcome Alison to the Aeglea Board at this pivotal stage of the company s growth. As we move closer to becoming a commercial-ready company, it is important to have a breadth of experience and diversity of perspective to help shape our strategy and accelerate our progress, said Anthony Quinn, M.B Ch.B, Ph.D., president and chief executive officer of Aeglea. We believe that this addition complements our Board s skills and experi ....

United States , City Of , United Kingdom , Aeglea Biotherapeutics , Genzyme Biosurgery , Anthony Quinn , Alison Lawton , Eli Lilly , Board Of Regulatory Affairs Professional Society , King College London , Merck Co , Advisory Committee , Gene Therapy Committee , Exchange Commission , Cubist Pharmaceuticals , Aeglea Biotherapeutics Inc , Aeglea Board , Kaleido Biosciences , Aura Biosciences , Global Market , Regulatory Affairs Professional Society , Gene Therapy , Rare Pediatric Disease , Breakthrough Therapy , Forward Looking Statements , Securities Litigation Reform Act ,